| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/13/2001 | EP1106186A2 Non-covalent bioconjugates useful for magnetic resonance imaging |
| 06/13/2001 | EP1106177A1 Tumor tissue accumulation enhancers for drugs |
| 06/13/2001 | EP1105528A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 06/13/2001 | EP1105399A1 Carboxylated phosphatidic acid esters |
| 06/13/2001 | EP1105162A1 Combination of a positive mri contrast agent with a negative mri contrast agent |
| 06/13/2001 | EP1067968A4 Methods for evaluating a compound for its effect on skin |
| 06/13/2001 | EP1066402A4 Methods of screening agents for activity using teleosts |
| 06/13/2001 | EP0820432B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/13/2001 | CN1299291A Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 06/13/2001 | CN1299249A Reagent for tumor therapy and/or imaging |
| 06/13/2001 | CN1066965C Ultrasonic gas suspensions and method for storage of same |
| 06/13/2001 | CN1066964C Microcapsules, method of making same and their use |
| 06/13/2001 | CN1066963C Contrast agent and improvement thereof |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245319 Colloidal dispersions of perfluoropentane |
| 06/12/2001 | US6245318 Selectively binding ultrasound contrast agents |
| 06/12/2001 | US6245316 Enhancement of delivery of radioimaging and radioprotective agents |
| 06/12/2001 | CA2154590C Phase shift colloids as ultrasound contrast agents |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/08/2001 | CA2322344A1 Non-covalent bioconjugates useful for magnetic resonance imaging |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040234A1 Porphyrin compound |
| 06/07/2001 | WO2001040233A1 Nitroimidazole-supporting porphyrin complex |
| 06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/07/2001 | WO2001039798A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | WO2001013946A3 Method for isolating and purifying grass pollen allergens |
| 06/07/2001 | US20010002993 For ultrasound imaging; injectable aqueous medium having gas dispersed therein and composition comprising a diffusible component capable of diffusion in vivo into said dispersed gas so as at least transiently to increase the size thereof |
| 06/07/2001 | US20010002992 Imaging means comprising an imaging agent attached to an agent that binds to a cell surface element of a mononuclear phagocyte; therapy of cancer or coronary heart disease |
| 06/07/2001 | DE19958586A1 Mikropartikel auf Basis von Asparaginsäure und deren Verwendung als MRI-Kontrastmittel Microparticles based on aspartic acid and their use as MRI contrast agents |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 06/07/2001 | CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 06/07/2001 | CA2368268A1 Porphyrin compounds |
| 06/07/2001 | CA2360829A1 Nitroimidazole substituted porphyrin complex |
| 06/06/2001 | EP1104761A1 Fluorescent labelling reagents |
| 06/06/2001 | EP1104678A2 Method for hyperthermic potentiation of tissue |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP0628284B1 Contact medium for probe of ultrasonic diagnostic apparatus |
| 06/05/2001 | US6243600 Method of magnetic resonance arteriography |
| 06/05/2001 | US6241968 Compositions for increasing the MRI contrast in visualizing the digestive tract of patients |
| 06/05/2001 | US6241967 Process and device for the production of liquid, disperse systems |
| 06/05/2001 | US6241966 Magnetic resonance imaging using Hyperpolarized noble gases |
| 06/05/2001 | US6241963 Dopamine and serotonin transporter ligands and imaging agents |
| 05/31/2001 | WO2001038344A2 Modulation of signal transduction |
| 05/31/2001 | WO2001037883A1 Complexes of alkylphosphonic acids |
| 05/31/2001 | WO2001037882A2 Use of fenoldepam for protecting against radio-contrast medium-induced renal dysfunction |
| 05/31/2001 | WO2001037870A1 Treatment of autoimmune diseases by an agonistic cd40-binding protein |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001037630A2 Imaging sexual response |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000072880A3 Prevention and treatment of amyloidogenic disease |
| 05/31/2001 | WO2000006712A3 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 05/31/2001 | WO1999024394A9 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 05/31/2001 | US20010002249 Luteinizing hormone releasing hormone (LHRH); reducing breast density for better imaging of breast tissue such as prior to mammograms |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2390802A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1102770A1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction |
| 05/30/2001 | EP0840570A4 Apparatus and method for making gas-filled vesicles of optimal size |
| 05/30/2001 | EP0719254B1 Method for the preparation of high purity substituted benz e]indoles and the alkaline salts thereof |
| 05/29/2001 | US6240311 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 05/29/2001 | US6239145 Usable in acquiring information about active oxygen or in vivo free radicals as biological images such as magnetic resonance images or magnetoencephalograms; |
| 05/29/2001 | US6238931 Particles with energy donors and acceptors as well as proteins, polypeptides, nucleic acids, or ligand analogues bound to surface; with reduced quenching and improved fluorescence intensities; immunoassays |
| 05/29/2001 | US6237363 Vapor phase; using syringe |
| 05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036617A2 Assay for measuring enzyme activity in vivo |
| 05/25/2001 | WO2001036510A2 Use of poly(diallylamine) polymers |
| 05/25/2001 | WO2001036005A2 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | WO2001035985A1 P-superfamily conopeptides |
| 05/25/2001 | WO2000061191A3 Heat stable coated colloidal iron oxides |
| 05/25/2001 | CA2391450A1 Targeted delivery of therapeutic and diagnostic moieties |
| 05/24/2001 | US20010001657 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
| 05/23/2001 | EP1101498A1 Drugs for therapeutic use enabling nuclear magnetic resonance diagnosis by scalar bond |
| 05/23/2001 | EP1100549A2 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 05/23/2001 | EP1100462A2 Methods of ophthalmic administration |
| 05/23/2001 | EP1100369A1 Method for marking red blood cells using a water-soluble fluorescent colouring agent |
| 05/23/2001 | EP0850262B1 Selectively functionalizable desdendrimers |
| 05/23/2001 | DE19952738A1 Verbesserte Suspensionen von Ultraschallkontrastmitteln Improved suspensions of ultrasound contrast agents |
| 05/22/2001 | US6235968 Detecting angiogenesis |
| 05/22/2001 | US6235967 Metastasis models using green fluorescent protein as a marker |
| 05/22/2001 | US6235475 Generating nucleotide sequence probes; generate nucleotide sequences, compare to library of nucleotide sequences, retain and synthesize preferential nucleotide sequences |
| 05/22/2001 | US6235264 Medical imaging method for characterizing tumor angiogenesis using polymeric contrast agents |
| 05/22/2001 | US6234971 Vascular catheter having low-profile distal end |
| 05/17/2001 | WO2000076550A3 Carrier-drug conjugate |
| 05/17/2001 | WO2000066180A8 Method for enhancing contrast produced by mri |
| 05/17/2001 | US20010001279 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098665A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | CN1295578A Pharmaceuticals for imaging of angiogenic disorders |
| 05/15/2001 | US6233481 Diagnostic application of sono-chemical excitation of fluorescent photosensitizers |
| 05/15/2001 | US6232525 Mutant plants and uses therefor |
| 05/15/2001 | US6232524 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 05/15/2001 | US6232523 To study tumor progresssion in vertebrates; stably transformed tumor cell line transfected with expression vector nucleotide sequence under control of viral promoter; continued expression through cell line proliferation |
| 05/15/2001 | US6232499 Process for the production of iodinated organic x-ray contrast agents |
| 05/15/2001 | US6232349 And polycarbonates, polyesters or polyamides water-soluble, with a rigid backbone and predictable anion spacing |
| 05/15/2001 | US6232295 Cell-specific contrast agent and gene delivery vehicles |